Correlation Between Cognition Therapeutics and Aravive
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Aravive, you can compare the effects of market volatilities on Cognition Therapeutics and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Aravive.
Diversification Opportunities for Cognition Therapeutics and Aravive
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cognition and Aravive is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Aravive go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Aravive
If you would invest 149.00 in Aravive on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Aravive or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Cognition Therapeutics vs. Aravive
Performance |
| Timeline |
| Cognition Therapeutics |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cognition Therapeutics and Aravive Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Aravive
The main advantage of trading using opposite Cognition Therapeutics and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |